These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7739744)

  • 1. [Oral treatment of onychomycosis of the toe nails; comparison of cost effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine].
    Jacobs AE
    Ned Tijdschr Geneeskd; 1995 Apr; 139(17):904-5. PubMed ID: 7739744
    [No Abstract]   [Full Text] [Related]  

  • 2. A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine.
    Angello JT; Voytovich RM; Jan SA
    Am J Manag Care; 1997 Mar; 3(3):443-50. PubMed ID: 10173095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oral treatment of onychomycosis of the toe nails; comparison of cost-effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine].
    Bergman W; Rutten FF
    Ned Tijdschr Geneeskd; 1994 Nov; 138(47):2346-50. PubMed ID: 7969635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral treatment of onychomycosis of the toe nails; comparison of cost effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine].
    Neumann HA
    Ned Tijdschr Geneeskd; 1995 Jul; 139(26):1350-1. PubMed ID: 7617054
    [No Abstract]   [Full Text] [Related]  

  • 5. The new oral antifungal agents for onychomycosis of the toenails.
    Gupta AK; Shear NH
    J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):1-13. PubMed ID: 10565624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoeconomic analysis of oral therapies for onychomycosis: a US model.
    Marchetti A; Piech CT; McGhan WF; Neugut AI; Smith BT
    Clin Ther; 1996; 18(4):757-77; discussion 702. PubMed ID: 8879902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.
    Casciano J; Amaya K; Doyle J; Arikian S; Shear N; Haspel M; Kahler K
    Manag Care; 2003 Mar; 12(3):47-54. PubMed ID: 12685377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
    Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
    Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of systemic antimycotics in dermatotherapy.
    Niewerth M; Korting HC
    Eur J Dermatol; 2000 Mar; 10(2):155-60. PubMed ID: 10694319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
    Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
    J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacoeconomic analysis of sequential treatment pathways in the treatment of onychomycosis.
    Frankum LE; Nightengale B; Russo CL; Sarnes M
    Manag Care Interface; 2005 Jan; 18(1):55-63. PubMed ID: 15682633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current trends in onychomycosis therapy: a literature review.
    Hecker D
    Mt Sinai J Med; 1997 Nov; 64(6):399-405. PubMed ID: 9364835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onychomycosis. Going for cure.
    Gupta AK; Shear NH
    Can Fam Physician; 1997 Feb; 43():299-305. PubMed ID: 9040916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toenail onychomycosis: current and future treatment options.
    Finch JJ; Warshaw EM
    Dermatol Ther; 2007; 20(1):31-46. PubMed ID: 17403258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis.
    Gupta AK; Ryder JE; Johnson AM
    Br J Dermatol; 2004 Mar; 150(3):537-44. PubMed ID: 15030339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
    Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
    J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis.
    Baran R
    Br J Dermatol; 2001 Oct; 145 Suppl 60():15-9. PubMed ID: 11777260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
    Ginter-Hanselmayer G; Weger W; Smolle J
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapies for onychomycosis: a review.
    Gupta AK; Tu LQ
    Dermatol Clin; 2006 Jul; 24(3):375-9. PubMed ID: 16798436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.